Cargando…
Technical advances in NK cell-based cellular immunotherapy
Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936239/ https://www.ncbi.nlm.nih.gov/pubmed/31908885 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0187 |
_version_ | 1783483706033307648 |
---|---|
author | Fang, Fang Wang, Wei Chen, Minhua Tian, Zhigang Xiao, Weihua |
author_facet | Fang, Fang Wang, Wei Chen, Minhua Tian, Zhigang Xiao, Weihua |
author_sort | Fang, Fang |
collection | PubMed |
description | Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic modification, manufacturing systems, clinical programs, and outcomes. Future prospects and challenges in NK cell immunotherapy are also discussed, including off-the-shelf NK cell exploitation, automatic and closed manufacturing systems, cryopreservation, and therapies involving regulatory checkpoints. |
format | Online Article Text |
id | pubmed-6936239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Chinese Anti-Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-69362392020-01-06 Technical advances in NK cell-based cellular immunotherapy Fang, Fang Wang, Wei Chen, Minhua Tian, Zhigang Xiao, Weihua Cancer Biol Med Review Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic modification, manufacturing systems, clinical programs, and outcomes. Future prospects and challenges in NK cell immunotherapy are also discussed, including off-the-shelf NK cell exploitation, automatic and closed manufacturing systems, cryopreservation, and therapies involving regulatory checkpoints. Chinese Anti-Cancer Association 2019-11 /pmc/articles/PMC6936239/ /pubmed/31908885 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0187 Text en Copyright 2019 Cancer Biology & Medicine http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Review Fang, Fang Wang, Wei Chen, Minhua Tian, Zhigang Xiao, Weihua Technical advances in NK cell-based cellular immunotherapy |
title | Technical advances in NK cell-based cellular immunotherapy |
title_full | Technical advances in NK cell-based cellular immunotherapy |
title_fullStr | Technical advances in NK cell-based cellular immunotherapy |
title_full_unstemmed | Technical advances in NK cell-based cellular immunotherapy |
title_short | Technical advances in NK cell-based cellular immunotherapy |
title_sort | technical advances in nk cell-based cellular immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936239/ https://www.ncbi.nlm.nih.gov/pubmed/31908885 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0187 |
work_keys_str_mv | AT fangfang technicaladvancesinnkcellbasedcellularimmunotherapy AT wangwei technicaladvancesinnkcellbasedcellularimmunotherapy AT chenminhua technicaladvancesinnkcellbasedcellularimmunotherapy AT tianzhigang technicaladvancesinnkcellbasedcellularimmunotherapy AT xiaoweihua technicaladvancesinnkcellbasedcellularimmunotherapy |